Estudos sobre a cinética de absorção do fósforo pelo arroz (Oryza sativa L.) e pelo feijoeiro (Phaseolus vulgaris L.)

Three experiments were conducted under controlled conditions with the objectives of evaluating the effect of different concentrations of phosphorus and on the presence of other ions on the kinetic of absorption. Excised roots of rice and bean were placed in aereated solutions containing increasing concentrations of NaH2PO4 (10-7 M to 5x10-2M) during 90 minutes. The rate of absorption (v = mmols P/g dry matter) and the kinetic constants Vmax and Km were determined. Similar procedure was used to to evaluate the interaction of Mg+2, Al+3, K+, N-NH4+, N-NO3- and N-ureia in the uptake of phosphorus during 120 minutes. In another experiment, the effect of the presence of Mg+2 and/for Al+3 in the uptake and redistribution of phosphorus, was evaluated by varying the external concentration (1 ppm, 5 ppm, 10 ppm and 20 ppm) during a period of 17 hours, and utilizing whole rice plants. It was observed a dual mechanism, with two phases following the Michaelis-Menten kinetics and with transition phase 1 - 50 x 10-5 M. The best explanation of the experimental data was obtained, by transforming the data in accordance with HOFSTEE (1952). Bean was more efficient than rice in the first phase of uptake (higher Vmax). Al+3 had a clear stimulatory effect on the uptake of phosphorus, promoting, however, the anion fixation in the root at lower concentrations. At the highest concentrations (20 ppm) of phosphorus this effect was not evident. No effect on the uptake was observed with Mg+2, K+ and different forms of nitrogen. Urea could have a depressive effect although, not significant. Possible mechanisms invelved are discussed.Objetivando caracterizar os efeitos das diferentes concentrações de fósforo e da presença de outros íons na cinética de absorção de radiofósforo, foram conduzidos ensaios em solução nutritiva, em condições ambientais controladas. Foram empregadas raízes destacadas de arrroz e feijão para os estudos com diferentes concentrações de fósforo no meio (10-7 M até 5 x 10-2 M) e para avaliar as interações promovidas por Mg+2, Al+3, K+, NH4+, N-NO3-, N-urêia no mecanismo de absorção por períodos de uma hora e meia a duas horas. Em plantas inteiras de arroz procurou-se avaliar os efeitos da presença de Mg e/ou alumínio na absorção e transporte de fósforo quando variava a concentração externa (1 ppm, 5 ppm, 10 ppm e 20 ppm) por um período de 17 horas. Foi constatado um mecanismo duplo de absorção com as duas fases seguindo a cinética simples de Michaelis-Menten, e com ponto de transição entre 1-50x10-5. A transformada de dados segundo Hofstee adaptou-se melhor à interpretação dos dados experimentais. Feijão foi mais eficientes na absorção que arroz para a primeira fase (maior Vmax). Alumínio apresentou efeito estimulatório nítido na absorção de fósforo, promovendo porém, a fixação do ânion na raiz quando consideradas as concentrações mais baixas. Em concentrações altas de P, este último efeito não foi evidenciado. Magnésio não promoveu maior absorção, nem maior transporte do que K+; o mesmo aconteceu com as diferentes formas de nitrogênio. Uréia poderia ter um efeito depressivo maior, embora não significativo. Discutem-se os prováveis mecanismos envolvidos nestas respostas

International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module

•We report INICC device-associated module data of 50 countries from 2010-2015.•We collected prospective data from 861,284 patients in 703 ICUs for 3,506,562 days.•DA-HAI rates and bacterial resistance were higher in the INICC ICUs than in CDC-NHSN's.•Device utilization ratio in the INICC ICUs was similar to CDC-NHSN's. Background: We report the results of International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2010-December 2015 in 703 intensive care units (ICUs) in Latin America, Europe, Eastern Mediterranean, Southeast Asia, and Western Pacific. Methods: During the 6-year study period, using Centers for Disease Control and Prevention National Healthcare Safety Network (CDC-NHSN) definitions for device-associated health care-associated infection (DA-HAI), we collected prospective data from 861,284 patients hospitalized in INICC hospital ICUs for an aggregate of 3,506,562 days. Results: Although device use in INICC ICUs was similar to that reported from CDC-NHSN ICUs, DA-HAI rates were higher in the INICC ICUs: in the INICC medical-surgical ICUs, the pooled rate of central line-associated bloodstream infection, 4.1 per 1,000 central line-days, was nearly 5-fold higher than the 0.8 per 1,000 central line-days reported from comparable US ICUs, the overall rate of ventilator-associated pneumonia was also higher, 13.1 versus 0.9 per 1,000 ventilator-days, as was the rate of catheter-associated urinary tract infection, 5.07 versus 1.7 per 1,000 catheter-days. From blood cultures samples, frequencies of resistance of Pseudomonas isolates to amikacin (29.87% vs 10%) and to imipenem (44.3% vs 26.1%), and of Klebsiella pneumoniae isolates to ceftazidime (73.2% vs 28.8%) and to imipenem (43.27% vs 12.8%) were also higher in the INICC ICUs compared with CDC-NHSN ICUs. Conclusions: Although DA-HAIs in INICC ICU patients continue to be higher than the rates reported in CDC-NSHN ICUs representing the developed world, we have observed a significant trend toward the reduction of DA-HAI rates in INICC ICUs as shown in each international report. It is INICC's main goal to continue facilitating education, training, and basic and cost-effective tools and resources, such as standardized forms and an online platform, to tackle this problem effectively and systematically

Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-U.S. institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection